SINGAPORE, Feb 14 (Reuters) - Singapore's Health Sciences Authority (HSA) said on Monday it has granted an interim authorisation for Novavax's COVID-19 vaccine.

The first batch of the Nuvaxovid vaccine is expected to arrive in Singapore in the next few months, the HSA said. (Reporting by Aradhana Aravindan in Singapore Editing by Ed Davies)